Exploring Keynote Bioanalysis 2020
Exploring Keynote Bioanalysis 2020 reveals several interesting facts.
- Presenters Sriram Subramaniam and Salaheldin S. Hamed respond to answer audience questions. FDA CDER's Small Business ...
- Susan K. Gregurick, PhD and Rebecca Baker, PhD present the Plenary
- Jinhui Zhang, CDER Office of Pharmaceutical Quality, discusses the Biologics Price Competition and Innovation Act (BPCI) Act ...
- Presented By: Roger Hayes, PhD and Andrew Roche, PhD Speaker Biography: Roger Hayes, PhD: Roger Hayes, PhD, is the ...
- Diaa Shakleya, CDER Office of Pharmaceutical Quality (OPQ), discusses
In-Depth Information on Keynote Bioanalysis 2020
Director of the Office of Translational Sciences (OTS) ShaAvhrée Buckman-Garner, MD, PhD, FAAP, opened the meeting ... Ruben Ayala, CDER Office Translational Sciences, discusses Zhen Zhang, CDER Office of Generic Drugs, explains the regulatory requirements for stability and how to identify and resolve ... Presenters Patrick Faustino, Jinhui Zhang, and Diaa Shakleya respond to audience questions. FDA CDER's Small Business and ...
Patrick Faustino, CDER Office of Pharmaceutical Quality (OPQ), provides context for
Stay tuned for more updates related to Keynote Bioanalysis 2020.